A construct with fluorescent indicators for conditional expression of miRNA
暂无分享,去创建一个
[1] Brian L. Gilmore,et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi , 2008, Proceedings of the National Academy of Sciences.
[2] C. T. Dann. New technology for an old favorite: lentiviral transgenesis and RNAi in rats , 2007, Transgenic Research.
[3] J. Hou,et al. Transgenic RNAi Depletion of Claudin-16 and the Renal Handling of Magnesium* , 2007, Journal of Biological Chemistry.
[4] Jörg B Schulz,et al. Silencing of the Pink1 Gene Expression by Conditional RNAi Does Not Induce Dopaminergic Neuron Death in Mice , 2007, International journal of biological sciences.
[5] V. Kim,et al. Processing of intronic microRNAs , 2007, The EMBO journal.
[6] G. Du,et al. Design of expression vectors for RNA interference based on miRNAs and RNA splicing , 2006, The FEBS journal.
[7] C. Benoist,et al. Modeling CTLA4-linked autoimmunity with RNA interference in mice , 2006, Proceedings of the National Academy of Sciences.
[8] Zuoshang Xu,et al. Allele-specific RNAi selectively silences mutant SOD1 and achieves significant therapeutic benefit in vivo , 2006, Neurobiology of Disease.
[9] R. Hammer,et al. Heritable and stable gene knockdown in rats. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[10] S. Barik. RNAi in moderation , 2006, Nature Biotechnology.
[11] Zuoshang Xu,et al. Transgenic RNAi: Accelerating and Expanding Reverse Genetics in Mammals , 2006, Transgenic Research.
[12] Theresa A. Storm,et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.
[13] B. Cullen. Induction of stable RNA interference in mammalian cells , 2006, Gene Therapy.
[14] M. Wilkinson,et al. Tissue-specific RNAi reveals that WT1 expression in nurse cells controls germ cell survival and spermatogenesis. , 2006, Genes & development.
[15] Zuoshang Xu,et al. Promises and Challenges in Developing RNAi as a Research Tool and Therapy for Neurodegenerative Diseases , 2006, Neurodegenerative Diseases.
[16] S. Melov,et al. Pol II–Expressed shRNA Knocks Down Sod2 Gene Expression and Causes Phenotypes of the Gene Knockout in Mice , 2005, PLoS genetics.
[17] S. Elledge,et al. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Kopchick,et al. Differentially Expressed Proteins in the Pancreas of Diet-induced Diabetic Mice* , 2005, Molecular & Cellular Proteomics.
[19] X. Coumoul,et al. Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference , 2005, Nucleic acids research.
[20] Parvesh Bubber,et al. Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications , 2005, Annals of neurology.
[21] V. Kim. MicroRNA biogenesis: coordinated cropping and dicing , 2005, Nature Reviews Molecular Cell Biology.
[22] Zuoshang Xu,et al. An RNA polymerase II construct synthesizes short-hairpin RNA with a quantitative indicator and mediates highly efficient RNAi , 2005, Nucleic acids research.
[23] G. Gibson,et al. Reduction in the E2k Subunit of the α-Ketoglutarate Dehydrogenase Complex Has Effects Independent of Complex Activity* , 2005, Journal of Biological Chemistry.
[24] B. Cullen,et al. Overexpression of exportin 5 enhances RNA interference mediated by short hairpin RNAs and microRNAs. , 2005, RNA.
[25] Erik L. L. Sonnhammer,et al. siRNAdb: a database of siRNA sequences , 2004, Nucleic Acids Res..
[26] A. Pegg,et al. Spermine Synthesis Is Required for Normal Viability, Growth, and Fertility in the Mouse* , 2004, Journal of Biological Chemistry.
[27] B. Cullen,et al. Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. , 2004, RNA.
[28] Gene W. Yeo,et al. Variation in sequence and organization of splicing regulatory elements in vertebrate genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Mello,et al. Revealing the world of RNA interference , 2004, Nature.
[30] Donald C. Chang,et al. A novel RNA splicing-mediated gene silencing mechanism potential for genome evolution. , 2003, Biochemical and biophysical research communications.
[31] J. Miyazaki,et al. Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis. , 2003, Biochemical and biophysical research communications.
[32] T. Du,et al. Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.
[33] Zuoshang Xu,et al. An enhanced U6 promoter for synthesis of short hairpin RNA. , 2003, Nucleic acids research.
[34] T. Pawson,et al. Transgenic RNA interference in ES cell–derived embryos recapitulates a genetic null phenotype , 2003, Nature Biotechnology.
[35] Michael T. McManus,et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference , 2003, Nature Genetics.
[36] G. Hannon,et al. Germline transmission of RNAi in mice , 2003, Nature Structural Biology.
[37] Inder M Verma,et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[38] M. Okabe,et al. Small interfering RNA and gene silencing in transgenic mice and rats , 2002, FEBS letters.
[39] K. Naito,et al. Expression of the gene of interest fused to the EGFP-expressing gene in transgenic mice derived from selected transgenic embryos. , 2002, The Journal of experimental zoology.
[40] J. Miyazaki,et al. Usefulness of double gene construct for rapid identification of transgenic mice exhibiting tissue‐specific gene expression , 2001, Molecular reproduction and development.
[41] V. W. Lui,et al. Specific down-regulation of HER-2/neu mediated by a chimeric U6 hammerhead ribozyme results in growth inhibition of human ovarian carcinoma. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[42] B. Blencowe. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.
[43] C. Lobe,et al. Z/AP, a double reporter for cre-mediated recombination. , 1999, Developmental biology.
[44] J. Jolles,et al. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia , 1998, Journal of the Neurological Sciences.
[45] L. Maquat,et al. A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. , 1998, Trends in biochemical sciences.
[46] Y. Yoo,et al. Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. , 1998, Biochemistry.
[47] S. Kish,et al. Brain protein and α‐ketoglutarate dehydrogenase complex activity in alzheimer‐s disease , 1996, Annals of neurology.
[48] S. Kish,et al. Brain α‐Ketoglutarate Dehydrotenase Complex Activity in Alzheimer's Disease , 1993 .
[49] R. Butterworth,et al. Thiamine-dependent enzyme changes in temporal cortex of patients with Alzheimer's disease , 1990, Metabolic Brain Disease.
[50] R. Moreno-Sánchez,et al. Influence of NAD-linked dehydrogenase activity on flux through oxidative phosphorylation. , 1990, The Biochemical journal.
[51] J. Blass,et al. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. , 1988, Archives of neurology.
[52] R. Hansford. Bioenergetics in aging. , 1983, Biochimica et biophysica acta.
[53] G. Cooney,et al. Tricarboxylic acid cycle flux and enzyme activities in the isolated working rat heart. , 1981, The Biochemical journal.
[54] Yi Xing,et al. ASAP: the Alternative Splicing Annotation Project , 2003, Nucleic Acids Res..
[55] S. Kish,et al. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. , 1993, Journal of neurochemistry.
[56] R. Amann,et al. Predictive Identification of Exonic Splicing Enhancers in Human Genes , 2022 .